Get the Stockscreener App
6.0213
2.85%
-0.2787
Quantum Biopharma Ltd stock is traded at $6.0213, with a volume of 21,462.
It is down -2.85% in the last 24 hours and up +8.13% over the past month.
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
See More
Previous Close:
$6.30
Open:
$6.16
24h Volume:
21,462
Relative Volume:
0.01
Market Cap:
$15.45M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.93%
1M Performance:
+8.13%
6M Performance:
-10.13%
1Y Performance:
+0.00%
1-Day Range:
$5.91
$6.2608
1-Week Range:
$5.91
$6.80
52-Week Range:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
6.0213 | 15.45M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
145.78 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.12 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.84 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.29 | 15.64B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
281.70 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Quantum BioPharma Announces RSU Grant and Debt Settlement - TipRanks
Quantum BioPharma Corporate Update - Newsfile
1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ - The Globe and Mail
West Fraser Timber Ltd Stock Analysis: Q1 2025 Earnings and Future Outlook - The Globe and Mail
Meta Platforms (META) Can Withstand an Advertising Slowdown, Says Citigroup - The Globe and Mail
Stocks Pressured by Fears of a Tariff-Induced Slowdown - The Globe and Mail
Why ServiceNow Stock Is Gaining Today - The Globe and Mail
What to Know About Jeff Bezos’ Secret EV Startup Slate Auto - The Globe and Mail
Allied Announces April 2025 Distribution - The Globe and Mail
Rocket Lab Stock (RKLB) Soars on Major Hypersonic Tech Deals with US and UK Governments - The Globe and Mail
Abbott Laboratories (ABT) Q1 Earnings: What To Expect - The Globe and Mail
BWXT Moving Forward to Support National Security, Domestic Uranium Enrichment Mission - The Globe and Mail
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhar - GuruFocus
Quantum BioPharma (QNTM) Prevails in Legal Dispute with Former C - GuruFocus
Quantum BioPharma wins legal battle against former CEO By Investing.com - Investing.com South Africa
Market Analysis: April 14th, 2025 - The Globe and Mail
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Canadian Insurance Market Remains Strong Amidst Market Volatility: Aon Report - The Globe and Mail
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Ignore - The Globe and Mail
Quantum BioPharma Secures Legal Victory with $180,000 Award - TipRanks
Quantum BioPharma wins legal battle against former CEO - Investing.com
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario - GlobeNewswire
Latest: Court Upholds $2.8M Award in Quantum BioPharma's Favor Against Former CEO - Stock Titan
2 AI Stocks That Could Help Set You Up for Life - The Globe and Mail
3 ETFs to Save Your Portfolio Right Now - The Globe and Mail
Are These 3 Retail Stocks Oversold or Really in Trouble? - The Globe and Mail
Should You Buy ChargePoint While It's Below $0.70? - The Globe and Mail
BMO Announces Election of Board of Directors - The Globe and Mail
Stocks in play: Bonterra Energy Corp - The Globe and Mail
Time to Load Up on the New Look of SCHD - The Globe and Mail
1 Undervalued Growth Stock You Can Buy During the Stock Market Drop of 2025 - The Globe and Mail
3 Reasons to Avoid SWIM and 1 Stock to Buy Instead - The Globe and Mail
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Pa - GuruFocus
Quantum BioPharma’s licensee expands retail reach with AATAC deal By Investing.com - Investing.com South Africa
Quantum BioPharma Licensee Celly Nutrition Partners With Asian American Trade Associations Council - marketscreener.com
Quantum BioPharma's licensee expands retail reach with AATAC deal By Investing.com - Investing.com India
Quantum BioPharma's licensee expands retail reach with AATAC deal - Investing.com
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™ - GlobeNewswire
Quantum's Alcohol Detox Drink Lands Massive Deal: Coming to 80,000+ US Stores - Stock Titan
4 Growth Stocks That Could Weather the Tariff Storm - The Globe and Mail
Altair Wins 2025 Google Cloud Business Applications Partner of the Year Award for Manufacturing - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Taiwan Semi Stock’s (TSM) Selloff Is ‘Overdone,’ Says BofA - The Globe and Mail
European Wax Center, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Lancaster Colony Stock (LANC) Defies Down Market on Record-Breaking Sales Performance - The Globe and Mail
Why Nvidia, Broadcom, and Taiwan Semiconductor Manufacturing Are Plunging Today - The Globe and Mail
Quantum BioPharma’s ‘unbuzzd’ Launches in Puerto Rico - TipRanks
Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico - The Manila Times
Quantum BioPharma Licensee Celly Nutrition Launches Unbuzzd In Puerto Rico - Barchart.com
3 Best Stocks to Buy Now, 4/3/2025, According to Top Analysts - The Globe and Mail
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):